Language selection

Search

Patent 2176960 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2176960
(54) English Title: NOVEL CARBAMATE COMPOUNDS AND PROCESSES FOR PREPARING THE SAME
(54) French Title: NOUVEAUX COMPOSES DE CARBAMATE ET LEURS PROCEDES DE PREPARATION
Status: Deemed expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12P 13/00 (2006.01)
  • C07C 271/08 (2006.01)
  • C07C 271/12 (2006.01)
  • C07C 271/16 (2006.01)
  • C07C 323/19 (2006.01)
  • C07D 213/30 (2006.01)
  • C07D 213/61 (2006.01)
  • C07D 213/69 (2006.01)
  • C07D 213/70 (2006.01)
(72) Inventors :
  • CHOI, YONG-MOON (United States of America)
  • HAN, DONG-IL (Republic of Korea)
  • LEE, KWANG-HYOUK (Republic of Korea)
  • KIM, HYUNG-CHEOL (Republic of Korea)
(73) Owners :
  • SK HOLDINGS CO., LTD. (Republic of Korea)
(71) Applicants :
  • YUKONG LIMITED (Republic of Korea)
(74) Agent: GOUDREAU GAGE DUBUC
(74) Associate agent:
(45) Issued: 2007-05-01
(86) PCT Filing Date: 1995-09-21
(87) Open to Public Inspection: 1996-03-28
Examination requested: 2002-09-09
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/KR1995/000124
(87) International Publication Number: WO1996/009283
(85) National Entry: 1996-05-17

(30) Application Priority Data:
Application No. Country/Territory Date
1994/23910 Republic of Korea 1994-09-22
1994/23912 Republic of Korea 1994-09-22
1994/23911 Republic of Korea 1994-09-22

Abstracts

English Abstract


(S)-2-aryl-1,3-propanediol and its intermediate, (5)-3-acetoxy-2-aryl-propanol carbamate, represented by formulae (I)
and (II), respectively, have pharmaceutically useful activity against central nervous system disorders including nervous myalgia, epilepsy
and cerebral apoplexy, wherein, R is (a), (b), (c), (d), (e), (f), (g), (h), (i) or (j), wherein X is an oxygen atom or 3 sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms.


French Abstract

Monocarbamate de (R)-2-aryl-1,3-propanediol et son intermédiaire, le carbamate de (R)-3-acétoxy-2-arylpropanol répondant respectivement aux formules (I) et (II), et présentant une activité pharmaceutiquement utile dirigée contre les troubles du système nerveux central tels que la myalgie nerveuse, l'épilepsie et l'apoplexie cérébrale. Dans lesdites formules, R représente (a), (b), (c), (d), (e), (f), (g), (h), (i) ou (j), où X représente un atome d'oxygène ou de soufre; et Y représente un élément halogène, trifluorométhyle ou un groupe alkyle inférieur renfermant de un à trois atomes de carbone.

Claims

Note: Claims are shown in the official language in which they were submitted.



24


WHAT IS CLAIMED IS:

1. (S)-2-Aryl-1,3-propanediol monocarbamate,
represented by the following Formula I:
Image
wherein, R is
Image
wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower
alkyl group containing one to three carbon atoms.
2. (S)-3-Acetoxy-2-arylpropanol carbamate,
represented by the following Formula II:


25


Image
wherein, R is
Image
wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower
alkyl group containing one to three carbon atoms.
3. A process for preparing (S)-3-acetoxy-2-
arylpropanol carbamate, represented by the following
Formula II:
Image
wherein, R is


26


Image
wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower
alkyl group containing one to three carbon atoms, in which
(R)-3-acetoxy-2-aryl-propanol, represented by the
following Formula III:
Image
wherein R is as defined above, is reacted with phosgene
in the presence of amine base in a solvent mixture of
aromatic hydrocarbon and halogenohydrocarbon and then with
ammonia, whereby a high optical purity can be obtained.
4. The process in accordance with claim 3, wherein
said solvent mixture comprises an aromatic hydrocarbon


27


selected from the group consisting of benzene, toluene and
xylene and a halogenohydrocarbon selected from the group
consisting of chloroform, dichloromethane, 1,2-
dichloroethane, and trichloroethane.
5. The process in accordance with claim 4, wherein
said solvent mixture comprises toluene and
dichloromethane.
6. The process in accordance with claim 3, wherein
said amine base is selected from the group consisting of
antipyrine, diisopropylethyl amine, diethyl amine,
triethyl amine and pyridine.
7. The process in accordance with claim 3, wherein
reaction temperature is -30 to 0 °C for phosgen and -70
°C to 0 °C for ammonia.
8. The process in accordance with claim 3, wherein
said ammonia condensed to liquid and is used in an excess
of 10 to 100 equivalents.
9. A process for preparing (S)-2-aryl-1,3-propanediol
monocarbamate, represented by the following Formula I:


28


Image
wherein, R is
Image
wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower
alkyl group containing one to three carbon atoms, in which
(S)-3-acetoxy-2-aryl-propanol carbamate, represented by
the following Formula II:
Image
wherein R is as defined above, is dissolved in a phosphate
buffer solution and added with a hydrolase selected from the
group consisting of a lipase extracted from pig's pancreas,
Candida lipase, Aspergillus lipase, Pseudomonas lipase and


29


an esterase extracted from pig's liver with vigorous
stirring, whereby a high optical purity can be obtained.
10. The process in accordance with claim 9, wherein
the reaction is carried out at a temperature of 0 to 35°C
under ordinary pressure.
11. The process in accordance with claim 9, wherein
said phosphate buffer solution has a pH of 6 to 9 and a
concentration of 0.01 to 0.1 M.
12. The process in accordance with claim 9, wherein
said hydrolase is an esterase extracted from pig's liver.

Description

Note: Descriptions are shown in the official language in which they were submitted.





R'O 96109283 2 ~ 7 6 9 6 0 PCTIKR95I00124
NOVEL CARBAMATE COMPOUNDS AND PROCESSES FOR PREPARING
THE SAME
BACRGROUND OF THE INVENTION
Field of the invention
The present invention relates, in general, to novel
enantiomeric carbamate compounds pharmaceutically useful
for central nervous disorders and, more particularly, to
(S)-2-aryl-1,3-propanediol monocarbamate derived from (R)-
3-acetoxy-2-arylpropanol carbamate and to (S)-3-acetoxy-2-
aryipropanol carbamate, its intermediate. Also, the
present invention is concerned with processes for
preparing the novel carbamate compounds.
Description of the Prior Art
Carbamates have been effectively used for controlling
central nervous system (hereinafter referred to as "CNS")
disorders, especially, as an antiepiletic and a centrally
acting muscle relaxant. For example, 2-methyl-2-propyl
1,3-propanediol dicarbamate was reported in J. Am. Chem.
Soc., 73, 5779 (1951), and the pharmaceutical activity
thereof was ascertained in J. Pharmacol. Exp. Ther., 104,
229 (1952).
U.S. Pat. No. 3,256,728 discloses that the compounds,
represented by the following general formula A, are
pharmaceutically useful therapeutics for CNS disorders.


WO 96/09283 ~ ~ 7 6 9 6 0 PCT/KR95/00124
2
R
Rz [A] '
~ R3
Z
wherein, R1 is a carbamate or methylene carbamate; RZ is
an alkyl group containing one or two carbon atoms, a
hydroxy alkyl group containing one or two carbon atoms,
hydroxy or hydrogen; R3 is hydrogen or an alkyl group
containing one or two carbon atoms; and Z represents a
halogen such as fluorine, chlorine, bromine or iodine, a
methylmethoxy group, a phenyl group, a vitro group or an
amine group.
Besides, other carbamate compounds which are very
useful therapeutic medicines against CNS disorders, in
particular, as antiepiletic and centrally acting muscle
relaxant, ate disclosed, including 2-phenyl-1,3-
propanediol dicarbamate in U.S. Pat. No. 2,884,444 and
isopropyl meprobamate in U.S. Pat. No. 2,937,119. At
present, various researches for such carbamate compounds
are being actively continued in the art.
SUMMARY OF THE INVENTION
Based on intensive and thorough study and research
by the present inventors, it was found that the carbamate
compounds represented by the following structural formulas
I and II are useful for the treatment and prevention of



W O 96109283 2 l 7 6 9 6 0 PCTlKR95100124
3
CNS diseases including nervous myalgia, epilepsy and
' cerebral apoplexy:
R ~ CH20H
[I]
CHZOCONHZ
R CH2OCOCH3
[II]
CHZOCONHZ
wherein, R is
O O Y O Y O XY O XY
' ' Y ' ' YX '
Y Y XY XY
r C~ or YX--~
N , N , , , N
wherein X is an oxygen atom or a sulfur atom; and Y
repre°- is a halogen element, trifluoromethyl, or a lower
alkyl ~~oup containing one to three carbon atoms.
In addition, taking advantage of the far superior
activity of single enantiomeric isomer to racemic mixture
in biological systems, the present inventors developed the
enantiomers of Formulas I and II, which had never been



WO 96109283 217 6 9 6 0 PCT~~00124
4
found, and applied them as pharmaceutically active
ingredients against CNS diseases.
The carbamate compounds of Formulas I and II are
chiral molecules with a chiral center of carbon at 2
propyl and may have either an (S) or (R)-configuration.
Accordingly, it is an-object of the present invention
to provide novel (S)-enantiomeric compounds represented
by Formulas I and II-, which have pharmaceutically useful
activity against central nervous system diseases.
It is another object of the present invention to
provide a method for preparing the compounds of Formulas
I and II at high yield and high purity within a short
time.
DETAILED DESCRIPTION OF THE INVENTION
The compound of Formula II can be prepared by
treating (R)-3-acetoxy-2-aryl-propanol, represented by the
following formula III:
R CHZOCOCH3
[III]
CHZOH
wherein, R is as defined above, with phosgene in a mixture
of aromatic hydrocarbon and halogenohydrocarbon in the
presence of amine base, and followed by anhydrous ammonia.
Available aromatic hydrocarbons include benzene,




WO 96109283 2 ~ 7 6 9 6 0 PCT/KR95/0012~1
toluene and xylene and a halogenohydrocarbon is selected


' from the group consisting of chloroform, dicholomethane,


1,2-dichloroethane and trichloroethane. The preferred



solvent is a mixture of toluene and dichloromethane.


5 As the amine base, antipyrine, diisopropylethylamine,


diethylamine, triethylamine or pyridine is available, with


a preference to such a sterically hindered base as


triethylamine, diisopropylethylamine or antipyrine.


Temperature is maintained at -30 to 0 'C upon


reaction with phosgene while the reaction with anhydrous


ammonia is carried out at a temperature of -70 to 0 'C.


For use, anhydrous ammonia is condensed to a liquid.


It is added at an excess of 10 to 100 equivalents and


preferably at an excess of 25 to 50 equivalents.


In accordance with the present invention, the


compound of Formula I can be converted from (S)-3-acetoxy-


2-aryl-propanol carbamate, represented by Formula II,


through the catalytic reaction of hydrolase in a buffer


solution. High yield and optical purity can be


accomplished within a short time by the enzymatic


hydrolysis of (S)-3-acetoxy-2-aryl-propanol carbamate into


(S)-2-aryl-1,3-propanediol monocarbamate.


Generally, enzymes show a far higher catalytic


activity than chemical catalysts while giving less by-


products.--In addition, since the enzymatic conversion
of


(S)-3-acetoxy-2-arylpropanol carbamate into (S)-2-aryl-


1,3-propanediol monocarbamate is carried out at a low





WO 96109283 t ' y ~ 2 l 7 6 9 6 0 PCT/KR95100124
6
temperature in a neutral aqueous solution, for example,
phosphate buffer solution, the side-reactions attributable '
to the enzyme can be eliminated. Following the
hydrolysis, the enzyme used can be almost completely
removed only by filtration without lowering the product
yield. Accordingly, the present invention is very
advantageous in time and cost.
In more detail, the (S)-3-acetoxy-2-arylpropanol
carbamate of Formula II is dissolved in a phosphate buffer
solution and then, vigorously stirred at a temperature of
0 to 35 'C and with ordinary pressure in the presence of
hydrolase. Preference is given to a temperature of 10 to
25 'C. Care must be taken to control the reaction
temperature. A reaction temperature of higher than 35 'C
makes the hydrolysis proceed faster but causes the enzyme
to be lowered in selectivity, deleteriously affecting the
optical purity of the product.
The phosphate buffer solution has a pH ranging from
6 to 9 with a preference of 7. For example, if the
phosphate buffer solution has a pH of higher or lower than
7, the optical purity of the product becomes poor. In
order for the selectivity of the enzyme not to be lowered,
the phosphate buffer solution is preferably diluted into
0.01 to 0.1 mole solution.
With regard to the hydrolase used for the conversion,
various sources are available. Representative examples
include lipase extracted from pig's pancreas (PPL),



WO 96109283 217 6 9 6 0 PCT/KR9510012.1
7
Candida lipase (CCL), Aspagillus lipase (ANL), Pseudomona5
' lipase (PSL) and an esterase from pig's liver (PLE), with
a preference for PLE.
Usually at 4 to 5 hours after adding the enzyme, the
conversion reaction of (S)-3-acetoxy-2-aryl-propanol
carbamate into (S)-2-aryl-1,3-propanediol monocarbamate
is terminated. Thin layer chromatography or high
performance liquid chromatography may be used to determine
the termination point of the conversion reaction.
From the resultant reaction mixture, the enzyme may
be filtered off simply and then, the solvent is removed
by using a rotary evaporator. Purification by column
chromatography gives (S)-2-aryl-1,3-propanediol
monocarbamate of Formula I, a novel compound.
Likewise, (R)-3-acetoxy-2-aryl-propanol of Formula
III can be prepared by use of an enzyme. For this, PPL,
CCL or PSL is immobilized to cellite. Preference is given
to PPL and PSL_ 2-aryl-1,3-propanediol is dissolved in
anhydrous alkyl acetate, such as methyl acetate, ethyl
acetate, propyl acetate and vinyl acetate, or anhydrous
alkenyl acetate and incubated at a temperature of -10 to
35 'C. Following this, the reactant is added with the
immobilized catalyst system in the absence of solvent
while vigorously stirring. At this moment, the reaction
is carried out preferably at a temperature of 0 to 35 'C
under ordinary pressure. Particularly, care must be taken
to control the temperature below 35 'C because higher



W O 96/09283 , ; ~ ; ' _ 2 ~ 7 6 9 6 0 PCTIKR95100124
8
temperature makes the reaction proceed too fast, resulting
in degradation of optical purity.
High performance liquid chromatography can also be
used about 3 hours-after the reaction, to determine the
termination of the reaction. Five hours after the
reaction is usual-ly enough to obtain the compound of
Formula III with a yield of 85 % or larger and an optical
purity of 99 % or more.
To identify (S)-2-aryl-1,3-propanediol monocarbamate
as a pharmaceutically useful material, anticonvulsant
activity assay of the novel compound of the present
invention was executed through standard Maximal Electro
Shock (MES) test. To the end, 0.5 g (S)-2-phenyl-1,3
propanediol monocarbamate was suspended in 100 ml buffer
solution at pH 7.4. The prepared suspension was
administered into ten male CD-2 mice weighing about 20 to
g at a dose of 300 mg/kg. Oral administration through
a syringe is preferred. At one hour after administration,
the middle of the forehead of the mice was electrically
20 shocked at 50 mA for 0.2 second by use of corneal
electrode. Of the ten mice administered with the compound
of the present invention, nine were not convulsed and
acted as usual_ Only one was convulsed. to death.
A better understanding of the present invention may
25 be obtained in light of following examples which are set
forth to illustrate, and are not to be construed to limit,
the present invention.



WO 96/09283 ~ 21 l 6 9 6 0 PCTJKR95/00124
9
EXAMPLE I
(S)-3-Acetoxy-Z-(2-pyridyl) propanol carbamate
500 ml flask equipped with a thermometer was well
dried and purged by flowing nitrogen gas into the inside
thereof for 30 min. After the moisture and air present
within the flask was replaced by nitrogen gas, 24.5 mI of
0.6 M phosgene solution was placed in the purged flask,
followed by the addition of 150 mI of toluene. The flask
was maintained at -30 'C in a bath containing dry ice and
acetone.
Separately, 2.0 g of (R}-3-acetoxy-2-(2-
pyridyl)propanol and 4.7 g of antipyrine were placed in
100 ml flask well dried. To this, 70 ml chloroform was
added.
To the phosgene/toluene solution maintained at -30
'C, the (R)-3-acetoxy-2-(Z-pyridyl) propanol solution was
dropwise added with a double-ended needle. Following the
completion of addition, thin layer chromatography was
executed to know whether the starting materials were
completely exhausted. Then, the reaction system was
cooled to -70 'C and slowly added with 50 g of liquid
ammonia. Reaction proceeded at -70 'C while stirring.
Excess ammonia present in the reaction mixture was blown
off by nitrogen gas at about 2 hours after the completion
of reaction. While precipitate was filtered off and the



W O 96109283 y ,, . j ~ ~ 7 6 ~ 6 p PCT/HIt95/0012~1
solvents, toluene and chloroform, were removed by use of
a rotary evaporator.
The resultant concentrated solution was subjected to
column chromatography (mobile phase: ethyl acetate),
5 giving forth (S)-3-acetoxy-2-(2-pyridyl) propanol
carbamate: Yield 84.0 $, purity 99.8 $.
Physical Properties of (S)-3-acetoxy-2-(2-pyridyl)
propanol carbamate: [a] _ + 45.3 ' (0.42 in acetone)
1H-NMR (CDC13, 200 MHz), ppm (b): 1.99 (s, 3H), 3.52
10 (q, IH), 4.43(m, 4H), 5.25 (br, 2H), 7.21(m, 2H), 7.68(m,
1H), 8.56(d, 1H)
EXAMPLE II
(S)-3-Acetoxy-2-(2-(3-chloro)pyridyl) propanol carbamate
The title compound was prepared in a similar manner
to that of Example I, except that (R)-3-acetoxy-2-(2-(3-
chloro)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-
pyridyl) propanol, was used as a starting material: Yield
68.3$. Purity 98.5 $.
[aJ = + 53.1 ' (0.50 in acetone)
EXAMPLE III
(S)-3-Acetoxy-2-(Z-(3-trifluoromethyl)pyridyl) propanol
carbamate




W O 96109283 ~ 1 T 6 9 6 0 PCT~~00124
11
The title compound was prepared in a similar manner
' to that of Example I, except that (R)-3-acetoxy-2-(2-(3-
trifluoromethyl)pyridyl) propanol, instead of (R)-3
acetoxy-2-(2-pyridyl) propanol, was used as a starting
material: Yield 63.2%. Purity 99.3 %.
[a] _ + 24.7 ° (0.50 in acetone)
EXAMPLE IV
(S)-3-Acetoxy-2-(2-(3-methyl)pyridyl) propanol carbamate
The title compound was prepared in a similar manner
to that of Example I, except that (R)-3-acetoxy-2-(2-(3-
methyl)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-
pyridyl) propanol, was used as a starting material: Yield
76.8 %. Purity 99.3 %.
[o] _ + 15.3 ° (0.50 in acetone)
EXAMPLE V
(S)-3-Acetoxy-2-(2-(3-thiomethyl)pyridyl) propanol
carbamate
Except that (R)-3-acetoxy-2-(2-(3-thiomethyl)pyridyl)
propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol,
was used as a starting material, Example I was repeated
to give the title compound: Yield 67.3%. Purity 99.1 %.




WO 96!09283 ~ ~ , :' . ... 'c y. 217 6 9 6 0 PCT~5100124
12
[a] _ + 37.8 ' (0.50 in acetone)
r
EXAMPLE VI
(S)-3-Acetoxy-2-(2-(4,6-dichloro)pyridyl) propanol
carbamate
Except that (R)-3-acetoxy-Z-(2-(4,6-dichloro)pyridyl)
propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol,
was used as a starting material, Example I was repeated
to give the title compound: Yield 70.1 %. Purity 99.2 %.
[a] _ + 48.3 ' (0.50 in acetone)
EXAMPLE VII
(S)-3-Acetoxy-Z-(2-(4,6-dimethoxy)pyridyl) propanol
carbamate
Except that (R)-3-acetoxy-2-(2-(4,6-
dimethoxy)pyridyl) propanol, instead of (R)-3-acetoxy-2-
(2-pyridyl) propanol, was used as a starting material,
Example I was repeated to give the title compound: Yield
72.9 %. Purity 98.9 %.
[n] _ + 24.1 ' (0.50 in acetone)




WO 96/09283 ~, . . , 217 b 9 6 Q PCT~S100124
13
EXAMPLE VIII
(S)-3-Acetoxy-2-phenylpropanol carbamate
In a Z50 mL flask equipped with a magnetic stirrer,
4.7 g of antipyrine (0.025 mole) and 1.94 g of (R)-3-
acetoxy-2-phenylpropanol (0.01 mole) were placed. 80 mL
of toluene and ZO mL of chloroform were poured into the
flask. The resulting reaction solution was maintained at
0 'C while stirring.
To the solution, 14 mL of 0.6 M phosgene was added
at 0 'C while stirring. White precipitate was evidence
that the reaction Was making progress. After five hours,
the reaction was terminated, and the reaction mixture was
subjected to filtration.
The filtrate was maintained at 0 'C and ammonia gas
was flowed into the flask for 30 minutes. After being
stirred for 30 minutes, the mixture was filtered to remove
precipitate. The solvents used were distilled off in
vacuo.
Isolation by column chromatography (using ethyl
acetate and n-hexane (1:1) as the mobile phase) gave (S)-
3-acetoxy-2-phenylpropanol carbamate: Yield 87.2 %. Purity
99.2 %.
Physical properties of (S)-3-acetoxy-2-phenylpropanol
carbamate: [a) _ + 2.5 ' (0.03 in CHC13)
ZS 1H-NMR (CDC13, 200 MHz), ppm (5): 1.99(s, 3H), 3.21-




WO 96109283 ~, , ~~ ~ -~ := 2 ~ 7 6 9 6 0 P~~SID0124
14
3.37(m, 1H), 4.21-4.38(m, 4H), 5.14(b, ZH), 7.21-7.30(m,
5H)
EXAMPLE IX
(S)-3-Acetoxy-2-(o-chlorophenyl)propanol carbamate
The title compound was synthesized in a similar
manner to that of Example VIII, except that (R)-3-acetoxy-
2-(o-chlorophenyl) propanol, instead of (R)-3-acetoxy-2-
phenyl propanol, Was used as a starting material. Yield
63.1 %.,Purity 99.3 %.
[a] _ + 13.7 ' (0.50 in methanol)
EXAMPLE X
(S)-3-Acetoxy-2-(o-trifluoromethylphenyl)propanol
carbamate
The title compound was synthesized in a similar
manner to that of Example VIII, except that (R)-3-acetoxy-
2-(o-trifluoromethyl phenyl) propanol, instead of (R)-3-
acetoxy-2-phenyl propanol, was used as a starting
material. Yield 63.1 %. Purity 99.6 %.
[a] _ + 32.5 ° (0.50 in methanol)




WO 96109283 _ 217 b 9 6 0 PCT/KR95100114
EXAMPLE XI
(S)-3-Acetoxy-2-(o-methylphenyl)propanol carbamate
The title compound was synthesized in a similar
manner to that of Example VIII, except that (R)-3-acetoxy-
5 2-(o-methylphenyl) propanol, instead of (R)-3-acetoxy-2-
phenyl propanol, was used as a starting material. Yield
78.7 %. Purity 98.5 %.
[a] _ + 8.3 ' (0.50 in methanol)
EXAMPLE XII
10 (S)-3-Acetoxy-2-(o-thiomethylphenyl) propanol carbamate
The title compound was synthesized in a similar
manner to that of Example VIII, except that (R)-3-acetoxy
2-(o-thiomethylphenyl) propanol, instead of (R)-3-acetoxy
2-phenyl propanol, was used as a starting material. Yield
15 60.3 %. Purity 99.4 %.
[a] _ + 21.9 ' (0.50 in methanol)
EXAMPLE XIII
(S)-3-Acetoxy-2-(2,4-dicholrophenyl) propanol carbamate
Except that (R)-3-acetoxy-2-(2,4-dichlorophenyl)



WO 96/09283 . ~ ~ T ~ g 6 ~ PCT/IiR95/00124
16
propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was
used as a starting material,-Example VIII was repeated to
give the title compound. Yield 67.5 $. Purity 99.7 ~.
[a] _ + 21.7 ° (0.50 in methanol)
EXAMPLE XIV
(S)-3-Acetoxy-2-(2,4-dimethoxyphenyl) propanol carbamate
Except that (R)-3-acetoxy-2-(2,4-dimethoxyphenyl)
propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was
used as a starting material, Example VIII was repeated
to give the title compound. Yield 63.0 ~. Purity 99.1 ~.
[a] _ + 12.4 ' (0.50 inmethanol)
EXAMPLE XV
(S)-2-(2-pyridyl)-1,3-propanediol monocarbamate
In a well dried 250 mL flask, 1.0 g of (S)-3-acetoxy-
2-(2-pyridyl)propanol carbamate obtained in Example I was
placed with 200 mL of 0.05 M phosphate buffer solution (pH
7) and 1.1 g of PLE-A and then, the resulting mixture was
vigorously stirred at a roomtemperature for five hours.
Subsequently, 200 mL of ethyl acetate was added to the
well stirred mixture, for solvent extraction. This




WO 96/09283 217 6 9 6 0 PCT/KR95/00124
17
extraction was repeated three times.
The ethyl acetate solution obtained was dried over
anhydrous magnesium sulfate. A rotary evaporator was used
to remove extra ethyl acetate. Isolation by column
chromatography gave (S)-2-(2-pyridyi)-1,3-propanediol
monocarbamate: Yield 60.0 %. Purity 99.5 %.
Physical properties of (S)-2-(2-pyridyl)-1,3-
propanediol carbamate: [a] _ + 24.1 ' (0.30 in acetone)
iH-NMR (CDC13, 200 MHz), ppm (b): 3.21(s, 1H),
3.66(m, 2H), 4.30(m,2H), 6.43(br, 2H), 7.31(m, 2H),
7.76(m, 1H), 8.53(d, 1H)
EBAMPLE XVI
(S)-2-(2-(3-Chloro)pyridyl)-1,3-propanediol monocarbamate
Except for using (S)-3-acetoxy-2-(2-(3-
cholro)pyridyl)propanol carbamate, instead of (S)-3-
acetoxy-2-(2-pyridyl.)propanol carbamate, as a starting
material, Example XV was repeated to give the title
compound: Yield 57.3 %. Purity 99.8 %.
[a] = t 27.8 ' (0.5D in methanol)
EXAMPLE XViI
(S)-2-(2-(3-Trifluoromethyl)pyridyl)-1,3-propanediol
monocarbamate



WO 96109283 217 6 9 b 0 PCT~S/0012d
' ! ~ a
18
Except for using (S)-3-acetoxy-2-(2-(3-
trifluoromethyl)pyridyl)propanol carbamate, instead of
(S)-3-acetoxy-2-(2-pyridyi)propanol carbamate, as a
starting material, Example XV was repeated to give the
S title compound: Yield 63.2 %. Purity 99.3 %.
(a] _ + 3.5 ° (0.50 in methanol)
EXAMPLE XVIII
(S)-2-(2-(3-Methyl)pyridyl)-1,3-propanediol monocarbamate
Except for using (S)-3-acetoxy-2-(2-(3-
methyl)pyridyl)propanol carbamate, instead of (S)-3-
acetoxy-2-(2-pyridyl)propanol carbamate, as a starting
material, Example XV was repeated .to give the title
compound: Yield 72.8 %. Purity 98.7 %.
[a] _ + 8.7 ' (0.50 in methanol)
EXAMPLE XIX
(S)-2-(2-(3-Thiomethyl)pyridyl)-1,3-propanediol
monocarbamate
Except for using (S)-3-acetoxy-2-(2-(3-
thiomethyl)pyridyl)propanoi carbamate, instead of (S)-3-
acetoxy-2-(2-pyridyl)propanol carbamate, as a starting
material, Example.XV was repeated to give the title




WO 96109283 F 217 6 9 6 Q PCT~5100124
19
compound: Yield 67.5 %. Purity 99.5 %.
' [a] _ + 20.4 ° (0.50 in methanol)
EXAMPLE XX
(S)-Z-(2-(4,6-dichloro)pyridyl)-1,3-propanediol
monocarbamate
The title compound was synthesized in a similar
manner to that of Example XV, except that (S)-3-acetoxy-2-
(2-(4,6-dichloro)pyridyl)propanol carbamate, instead of
(S)-3-acetoxy-2-(2-pyridyl)propanol carbamate, was used
as a starting material. Yield 60.5 %. Purity 99.5 %.
[a] _ + 33.1 ' (0.50 in methanol)
EXAMPLE XXI
(S)-2-(2-(4,6-dimethoxy)pyridyl)-1,3-propanediol
monocarbamate
The title compound was synthesized in a similar
manner to that of Example XV, except that (S)-3-acetoxy-2-
(2-(4,6-dimethoxy)pyridyl)propanol carbamate, instead of
(S)-3-acetoxy-2-(2-pyridyl) propanol carbamate, was used
as a starting material. Yield 70.4 %. Purity 99.5 %.
[a] _ + 11.8 ° (0.50 in methanol)




WO 96109283 G, .:.:. 217 6 9 6 p P'T'~'~S~oorz~ ~
EXAMPLE XXII
(S)-2-Phenyl-1,3-propanediol monocarbamate
In a 500 mL flask equipped with a magnetic stirrer,
2.37 g of (S)-3-acetoxy-2-phenylpropanol carbamate (0.01
5 mole) obtained in Example VIII was placed and 200 mL of
phosphate buffer solution (0.014 mole, pH 7) and 1.2 g of
PLE-A were added. The reaction mixture was stirred at
room temperature.
When the conversion rate of (S)-3-acetoxy-2
10 phenylpropanol carbamate reached 90 %, which was detected
by HPLC, the reaction was stopped and the resulting
mixture was filtered. The filtrate was extracted three
times with ethyl acetate, to isolate an organic layer of
which the extra solvent was then distilled off by a rotary
I5 evaporator. Isolation by column chromatography using a
mixture of ethyl acetate and n-hexane (1:1) as the mobile
phase gave (S)-2-phenyl-1,3-propanediol monocarbamate:
Yield 70.1 %. Purity 99.7 %.
Physical properties of (S)-2-phenyl-1,3-propanediol
20 monocarbamate: [c] = f 1.8 ' (0.03 in ethanol)
1H-NMR (CDC13, 200 MHz), ppm (b): 2.49-2.63(m, 1H),
2.95-3.21(m, IH), 3.75-3.88(m, ZH), 4.37(d, 2H), 4.91(b,
2H), 7.21-7.36(m, 5H)



WO 96/09283 ~ 2 l 7 6 9 6 Q P~~S/00124
21
EXAMPLE XXIII
v
(S)-2-(o-Chlorophenyl)-1,3-propanediol monocarbamate
The title compound was synthesized in a similar
manner to that of Example XXII, except that (S)-3-acetoxy-
2-(o-cholrophenyl)propanol carbamate, instead of (S)-3-
acetoxy-2-phenylpropanol carbamate, was used as a starting
material. Yield 76.3 %. Purity 99.3 %.
[a] _ + 8.7 ' (0.50 in methanol)
EXAMPLE XXIV
(S)-2-(o-Trifluoromethylphenyl)-1,3-propanediol
monocarbamate
The title compound was synthesized in a similar
manner to that of Example XXII, except that (S)-3-acetoxy-
2-(o-trifluoromethylphenyl)propanol carbamate, instead of
(S)-3-acetoxy-2-phenylpropanoi carbamate, was used as a
starting material. Yield 63.5 %. Purity 99.4 %.
[Q] _ + 21.3 ' (0.50 in methanol)
EXAMPLE XXV
(S)-2-(o-methylphenyl)-1,3-propanediol monocarbamate



WO 9Gl09283 217 6 9 6 fl PCT/KR95/00124
22
The title compound was synthesized in a similar
manner to that of Example XXII, except that (S)-3-acetoxy-
2-(o-methylphenyl)propanol carbamate, instead of (S)-3-
acetoxy-2-phenylpropanol carbamate, was used as a starting
material. Yield 78.3 %. Purity 99.0 %.
[a] = t 5.2 ' (0.50 in methanol)
EXAMPLE XXVI
(S)-2-(o-Thiomethylphenyl)-1,3-propanediol monocarbamate
The title compound was synthesized in a similar
manner to that of Example XXII, except that (S)-3-acetoxy-
2-(o-thiomethyiphenyl)propanol carbamate, instead of (S)-
3-acetoxy-2-phenylpropanol carbamate, was used as a
starting material. Yield 75.7 %. Purity 98.7 %.
[a] _ + 18.2 ' (0.50 in methanol)
EXAMPLE XXVII
(S)-2-(2,4-Dichlorophenyl)-1,3-propanediol monocarbamate
The title compound was synthesized in a similar
manner to that of Example XXII, except that (S)-3-acetoxy-
2-(2,4-dichlorophenyl)propanol carbamate, instead of (S)-
3-acetoxy-2-phenylpropanol carbamate, was used as a
starting material. Yield 78.9 %. Purity 99.7 %.



W096109283 " - PCTlKR95100124
X176960
23
[a] _ + 18.0 ' (0.50 in methanol)
EXAMPLE XXVIII
(S)-2-(2,4-dimethoxyphenyl)-1,3-propanediol monocarbamate
The title compound was synthesized in a similar
manner to that of Example XXII, except that (S)-3-acetoxy-
2-(2,4-dimethoxyphenyl)propanol carbamate, instead of (S)-
3-acetoxy-2-phenylpropanol carbamate, was used as a
starting material. Yield 65.3 ~. Purity 99.2 ~.
[a] _ + 25.1 ' (0.50 in methanol)
Other features, advantages and embodiments of the
present invention disclosed herein will be readily
apparent to those exercising ordinary skill after reading
the foregoing disclosures. In this regard, while specific
embodiments of the invention have been described in
considerable detail, variations and modifications of these
embodiments can be effected without departing from the
spirit and scope of the invention as described and
claimed.

Representative Drawing

Sorry, the representative drawing for patent document number 2176960 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2007-05-01
(86) PCT Filing Date 1995-09-21
(87) PCT Publication Date 1996-03-28
(85) National Entry 1996-05-17
Examination Requested 2002-09-09
(45) Issued 2007-05-01
Deemed Expired 2009-09-21

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1996-05-17
Registration of a document - section 124 $0.00 1996-08-15
Maintenance Fee - Application - New Act 2 1997-09-22 $100.00 1997-08-27
Maintenance Fee - Application - New Act 3 1998-09-21 $100.00 1998-08-06
Maintenance Fee - Application - New Act 4 1999-09-21 $100.00 1999-09-07
Maintenance Fee - Application - New Act 5 2000-09-21 $150.00 2000-07-27
Maintenance Fee - Application - New Act 6 2001-09-21 $150.00 2001-08-14
Request for Examination $400.00 2002-09-09
Maintenance Fee - Application - New Act 7 2002-09-23 $150.00 2002-09-09
Maintenance Fee - Application - New Act 8 2003-09-22 $150.00 2003-09-09
Maintenance Fee - Application - New Act 9 2004-09-21 $200.00 2004-09-07
Maintenance Fee - Application - New Act 10 2005-09-21 $250.00 2005-09-06
Registration of a document - section 124 $100.00 2006-01-31
Maintenance Fee - Application - New Act 11 2006-09-21 $250.00 2006-08-28
Final Fee $300.00 2007-02-12
Maintenance Fee - Patent - New Act 12 2007-09-21 $250.00 2007-09-10
Registration of a document - section 124 $100.00 2007-12-20
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
SK HOLDINGS CO., LTD.
Past Owners on Record
CHOI, YONG-MOON
HAN, DONG-IL
KIM, HYUNG-CHEOL
LEE, KWANG-HYOUK
SK CORPORATION
YUKONG LIMITED
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 1995-09-21 6 79
Cover Page 1995-09-21 1 15
Description 1995-09-21 23 429
Abstract 1995-09-21 1 35
Claims 2006-02-22 6 109
Cover Page 2007-04-26 1 36
Abstract 2007-04-30 1 35
Description 2007-04-30 23 429
Fees 2001-08-14 1 40
Fees 2006-08-28 1 46
Assignment 1996-05-17 8 336
Prosecution-Amendment 2002-09-09 1 30
PCT 1996-05-17 2 115
Fees 2003-09-09 1 34
Fees 2004-09-07 1 38
Fees 1997-08-27 1 51
Fees 1998-08-06 1 50
Fees 1999-09-07 1 45
Fees 2002-09-09 1 44
Fees 2000-07-27 1 40
Assignment 2006-01-31 2 56
Prosecution-Amendment 2006-02-22 9 192
Fees 2005-09-06 1 35
Prosecution-Amendment 2005-08-25 2 55
Correspondence 2007-02-12 1 33
Fees 2007-09-10 1 44
Assignment 2007-12-20 13 728